People who take angiotensin converting enzyme inhibitors (ACE-i) or angiotensin II receptor blockers (ARBs) for conditions such as high blood pressure were less likely to be diagnosed with colorectal cancer after having a normal colonoscopy. This is the first study to show potential benefits on colorectal cancer development from these commonly prescribed hypertension medications, based on a study of more than 185,000 patients.